Related Experiment Videos
Anaerobic disease of the lung
1Division of Infectious Disease, Louisiana State University Medical Center, New Orleans.
Abstract:
Anaerobic pleuropulmonary infections present in various ways. Aspiration pneumonitis occurs first and may be quite difficult to distinguish from the acute bacterial pneumonia caused by Streptococcus pneumoniae and other organisms. Although aspiration pneumonitis may be self-limiting, sequelae such as lung abscess, necrotizing pneumonia, and empyema can develop. Empiric antimicrobial therapy is now acceptable. The initial choice of antimicrobial agents is based on which pathogens are likely to be involved.
Insights
Anaerobic pleuropulmonary infections can be challenging to diagnose, often mimicking bacterial pneumonia. Early antimicrobial therapy is recommended, guided by likely pathogens, to prevent serious complications like lung abscess.
Area of Science:
- Infectious Diseases
- Pulmonology
Background:
- Anaerobic pleuropulmonary infections manifest diversely.
- Aspiration pneumonitis is an initial presentation, often confused with Streptococcus pneumoniae pneumonia.
- Complications include lung abscess, necrotizing pneumonia, and empyema.
Purpose of the Study:
- To review the presentation and management of anaerobic pleuropulmonary infections.
- To highlight the diagnostic challenges and potential sequelae.
Main Methods:
- Literature review of anaerobic pleuropulmonary infections.
- Analysis of clinical presentations and treatment strategies.
Main Results:
- Aspiration pneumonitis is a common initial manifestation.
- Distinguishing from bacterial pneumonia can be difficult.
- Empiric antimicrobial therapy is a current standard.
Conclusions:
- Prompt diagnosis and treatment are crucial for anaerobic pleuropulmonary infections.
- Antimicrobial selection should target probable pathogens.
- Management aims to prevent severe sequelae.